Pulmonary Disease Doctors in Camden, NJ Accepting Medicare

6 Pulmonary Disease doctors found. Showing 1 - 6

Mira Mandal, Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 2 Cooper Plz, Camden, NJ 08103 Phone: 856-795-3597    Fax: 856-735-6455

Ziad C Boujaoude, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 215, Camden, NJ 08103 Phone: 856-342-2439    Fax: 856-342-7832

Jonathan E Kass, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 215, Camden, NJ 08103 Phone: 856-342-2439    Fax: 856-342-7832

Ramya Lotano, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 312, Camden, NJ 08103 Phone: 856-342-2406    Fax: 856-541-3968

Dr. Vadim Divilov, MD Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000

Melvin Pratter, Internal Medicine - Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 3 Cooper Plz, Suite 312, Camden, NJ 08103 Phone: 856-342-2406

News Archive

Employers complain about health law's costly 'sleeper fee'

The Associated Press reports on a new, $63-per-person charge, which will be levied for three years beginning in 2014 to "cushion" the cost of covering people with pre-existing conditions and to stabilize the insurance market. Large employers say it works out to tens of millions in added costs which are likely to be passed onto workers.

New finding on key protein opens door to potential therapies for chronic illnesses

Scientists have determined unexpected characteristics of a key protein linked to blood pressure control and to nerve growth, pain control and heart tissue regeneration. The findings, published April 5 online in the journal Nature, opens doors to potential new therapies to control cardiovascular disease and pain.

Barr announces tentative approval for generic version of Effexor tablets

Barr Pharmaceuticals, Inc. has announced that its subsidiary PLIVA has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Wyeth Pharmaceuticals Inc.'s Effexor (Venlafaxine Hydrochloride) Tablets, 25mg, 37.5mg, 50mg, 75mg and 100mg.

Simple count of social determinants of health may help predict patients' fatal heart disease risks

Doctors may be able to predict their patients' risks of fatal coronary heart disease more accurately by taking into account the number of adverse social factors affecting them, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Read more Medical News

› Verified 3 days ago